<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cardiovasc Ultrasound</journal-id>
      <journal-title>Cardiovascular Ultrasound</journal-title>
      <issn pub-type="epub">1476-7120</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19573250</article-id>
      <article-id pub-id-type="pmc">2714075</article-id>
      <article-id pub-id-type="publisher-id">1476-7120-7-31</article-id>
      <article-id pub-id-type="doi">10.1186/1476-7120-7-31</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The subaortic tendon as a mimic of hypertrophic cardiomyopathy</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Ker</surname>
            <given-names>James</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>jker@wol.co.za</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Physiology, University of Pretoria, Pretoria, South Africa, PO Box 24318, Gesina, Pretoria, South Africa 0031</aff>
      <pub-date pub-type="collection">
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>7</month>
        <year>2009</year>
      </pub-date>
      <volume>7</volume>
      <fpage>31</fpage>
      <lpage>31</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.cardiovascularultrasound.com/content/7/1/31"/>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>6</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>7</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2009 Ker; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <copyright-holder>Ker; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Ker
               James
               
               jker@wol.co.za
            </dc:author><dc:title>
            The subaortic tendon as a mimic of hypertrophic cardiomyopathy
         </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Cardiovascular Ultrasound 7(1): 31-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1476-7120(2009)7:1&#x0003c;31&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1476-7120</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <p>Originally described by Brock and Teare, today hypertrophic cardiomyopathy is clinically defined as left (or right) ventricular hypertrophy without a known cardiac or systemic cause, such as systemic hypertension, Fabry's disease or aortic stenosis.</p>
        <p>Also appreciated today is the enormous genotypic and phenotypic heterogeneity of this disease with more than 300 mutations over more than 24 genes, encoding various sarcomeric, mitochondrial and calcium-handling proteins, all as genetic causes for hypertrophic cardiomyopathy.</p>
        <p>Phenotypically, the disease can vary from negligible to extreme hypertrophy, affecting either the left and/or right ventricle in an apical, midventricular or subaortic location.</p>
        <p>Left ventricular false tendons are thin, fibrous or fibromuscular structures that traverse the left ventricular cavity. Recently, a case report was presented where it was shown that such a false tendon, originating from a subaortic location, was responsible for striking ST-segment elevation on the surface electrocardiogram.</p>
        <p>In this case report, a case is presented where such a subaortic tendon led to the classic echocardiographic appearance of hypertrophic cardiomyopathy, thus in the assessment of hypertrophic cardiomyopathy, this entity needs to be excluded in order to prevent a false positive diagnosis of hypertrophic cardiomyopathy.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Hypertrophic cardiomyopathy (HCM) was first described in 2 publications between 1957&#x2013;1959 by Brock [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. During this period Teare [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>] also described the entity of asymmetrical septal hypertrophy in 8 autopsy cases.</p>
      <p>HCM is the most prevalent genetic cardiovascular disease, as it affects one in 500 individuals and exhibits enormous genotypic and phenotypic heterogeneity [<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>Phenotypically, hypertrophy can vary from negligible to extreme &#x2013; similarly fibrosis and myocyte disarray can also range from negligible to extreme [<xref ref-type="bibr" rid="B5">5</xref>]. This phenotypic variation is the result of the vast array of mutations present in the family of HCM [<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>These mutations can be inherited (familial) or can occur de novo (sporadic) [<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>Currently, more than 300 mutations, which are scattered over more than 24 genes are known as causes for HCM [<xref ref-type="bibr" rid="B5">5</xref>]. These involved genes encode various proteins of the sarcomere, mitochondria and the calcium-handling apparatus [<xref ref-type="bibr" rid="B5">5</xref>]. Sarcomeric mutations can affect the thick myofilament (beta-myosin heavy chain, regulatory myosin light chain and essential myosin light chain), the intermediate myofilament (myosin binding protein C) or the thin myofilament (cardiac troponins T and I, alpha-tropomyosin and actin) [<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>It is thus no wonder that the clinical presentation can range from apical hypertrophy, mid-ventricular hypertrophy, concentric hypertrophy and subaortic hypertrophy of the left and/or right ventricle [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B10">10</xref>].</p>
      <p>Of all these variants, hypertrophic obstructive cardiomyopathy (HOCM) is the variant that has been studied the most [<xref ref-type="bibr" rid="B8">8</xref>]. In this entity (previously known as idiopathic, hypertrophic, subaortic stenosis) asymmetrical, septal hypertrophy is accompanied by the following three elements [<xref ref-type="bibr" rid="B8">8</xref>]: systolic anterior motion (SAM) of the anterior leaflet of the mitral valve; a left ventricular outflow tract (LVOT) gradient and mitral regurgitation.</p>
      <p>Left ventricular false tendons are thin, fibrous or fibromuscular structures that traverse the left ventricular cavity and they may be single or multiple [<xref ref-type="bibr" rid="B11">11</xref>]. Recently, it was demonstrated that such a left ventricular false tendon, attached to the subaortic portion of the interventricular septum, led to striking ST-segment elevation on the surface electrocardiogram [<xref ref-type="bibr" rid="B12">12</xref>]. In this case report another possible diagnostic pitfall that can arise due to the presence of a subaortic tendon is presented.</p>
    </sec>
    <sec>
      <title>Case report</title>
      <p>A case report is presented where it is shown that a left ventricular false tendon, when attached to the subaortic portion of the interventricular septum &#x2013; a subaortic tendon &#x2013; can mimic the echocardiographic appearance of hypertrophic cardiomyopathy.</p>
      <p>A 30-year old Caucasian male was referred for a cardiovascular examination by his primary care physician. The clinical reason for the referral was the presence of a soft, subaortic midsystolic murmur (Levine grade I). The patient was totally asymptomatic and no previous medical or surgical problems were present. Clinical examination confirmed the grade I, subaortic, midsystolic murmur. The rest of the clinical examination was normal.</p>
      <p>Echocardiography demonstrated a classical parasternal long axis picture of hypertrophic cardiomyopathy, with the phenotype of subaortic hypertrophy (see additional file <xref ref-type="supplementary-material" rid="S1">1</xref>, <xref ref-type="supplementary-material" rid="S2">2</xref>, <xref ref-type="supplementary-material" rid="S3">3</xref> and <xref ref-type="supplementary-material" rid="S4">4</xref>). However, no systolic anterior motion of the mitral valve (SAM) and no left ventricular outflow tract gradient were present.</p>
      <p>However, further examination revealed the presence of a big, muscular, subaortic tendon, running parallel to the interventricular septum and giving the false impression of hypertrophic cardiomyopathy. See additional file <xref ref-type="supplementary-material" rid="S2">2</xref> demonstrating this muscular tendon clearly as a separate structure.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The echocardiographic assessment of ventricular hypertrophy is an extremely important component of the cardiovascular examination and it is also one of the most difficult clinical scenario's because of the vast array of pathologies, each one with a different prognosis.</p>
      <p>Shapiro <italic>et al </italic>[<xref ref-type="bibr" rid="B13">13</xref>] performed a prospective, echocardiographic examination to determine the prevalence of localized, subaortic hypertrophy in 1000 consecutive patients presenting for a routine echocardiographic examination. They excluded patients with hypertrophic cardiomyopathy and 8 cases of such localized, subaortic hypertrophy were found. In their series, localized subaortic hypertrophy was diagnosed when the subaortic septum was 50% thicker than the mid-point of the septum.</p>
      <p>Numerous diseases can lead to secondary left ventricular hypertrophy, which may then imitate hypertrophic cardiomyopathy [<xref ref-type="bibr" rid="B14">14</xref>] Jategaonkar <italic>et al </italic>described a case of HCM, with all the components of HOCM &#x2013; asymmetric septal hypertrophy, SAM and mitral regurgitation &#x2013; which turned out to be all due to an underlying pheochromocytoma [<xref ref-type="bibr" rid="B14">14</xref>]. Another important condition to exclude when localized, subaortic hypertrophy is found is hyperparathyroidism, as it has been shown that this condition is another important mimic of hypertrophic cardiomyopathy [<xref ref-type="bibr" rid="B15">15</xref>]. In the analysis of so-called "hypertrophic cardiac syndromes", they are often distinguished from one another by features such as: valvular abnormalities, outflow tract obstruction, electrocardiographic patterns, the presence or absence of diastolic dysfunction, as well as the degree and pattern of ventricular hypertrophy [<xref ref-type="bibr" rid="B16">16</xref>].</p>
      <p>Amyloidosis causes the accumulation of amyloid in the myocardial interstitium and this process ultimately leads to a ventricle with a firm, rubbery consistency and ventricular hypertrophy [<xref ref-type="bibr" rid="B16">16</xref>]. Two-dimensional strain is a unique imaging mode that permits the objective analysis of myocardial motion throughout the entire cardiac cycle [<xref ref-type="bibr" rid="B16">16</xref>]. Sun <italic>et al </italic>[<xref ref-type="bibr" rid="B16">16</xref>] studied the ability of two-dimensional strain to assess global and regional function in patients with amyloidosis, hypertrophic cardiomyopathy and hypertrophy due to hypertension. They were able to demonstrate that patients with "amyloid cardiomyopathy" had significantly lower myocardial deformation as seen by two-dimensional strain imaging than patients with hypertrophic cardiomyopathy and hypertensive hypertrophy. Thus, two-dimensional strain imaging can be added to the armamentarium of the echocardiographer in the assessment of idiopathic ventricular hypertrophy.</p>
      <p>Another good example of how a meticulous echocardiographic examination can detect the presence of a specific and unusual cause for severe ventricular hypertrophy, is Fabry's disease &#x2013; an X-linked metabolic storage disease where glycosphingolipid accumulates in the myocardium and other tissues, due to deficient activity of the enzyme alpha-galactosidase A [<xref ref-type="bibr" rid="B17">17</xref>]. The endocardium in Fabry's cardiomyopathy has a peculiar binary appearance, detectable by transthoracic echocardiography [<xref ref-type="bibr" rid="B17">17</xref>].</p>
      <p>Thus, it is clear that not all cases of subaortic hypertrophy are due to hypertrophic cardiomyopathy.</p>
      <p>This case report adds another mimic of hypertrophic cardiomyopathy to the list &#x2013; that of the muscular subaortic tendon.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>James Ker is the sole author</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author declares that they have no competing interests.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="S1">
        <caption>
          <title>Additional file 1</title>
          <p><bold>Parasternal long axis view</bold>. This is a movie clip, demonstrating the classical echocardiographic picture of the subaortic hypertrophy variant of hypertrophic cardiomyopathy (HCM).</p>
        </caption>
        <media xlink:href="1476-7120-7-31-S1.avi" mimetype="video" mime-subtype="x-msvideo">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S2">
        <caption>
          <title>Additional file 2</title>
          <p><bold>Closer view of subaortic tendon</bold>. This is a closer view of the basal interventricular septum. The thick, muscular subaortic tendon is clearly visible as a separate structure, giving the initial impression of hypertrophic cardiomyopathy.</p>
        </caption>
        <media xlink:href="1476-7120-7-31-S2.bmp" mimetype="image" mime-subtype="bmp">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S3">
        <caption>
          <title>Additional file 3</title>
          <p><bold>Parasternal long axis view</bold>. Another movie clip, once again from the parasternal long axis view, demonstrating the subaortic hypertrophy.</p>
        </caption>
        <media xlink:href="1476-7120-7-31-S3.wpl" mimetype="text" mime-subtype="plain">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S4">
        <caption>
          <title>Additional file 4</title>
          <p><bold>Subaortic hypertrophy</bold>. Note the appearance of severe, subaortic hypertrophy.</p>
        </caption>
        <media xlink:href="1476-7120-7-31-S4.bmp" mimetype="image" mime-subtype="bmp">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fifer</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Vlahakes</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Management of symptoms in hypertrophic cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>2008</year>
          <volume>117</volume>
          <fpage>429</fpage>
          <lpage>439</lpage>
          <pub-id pub-id-type="pmid">18212300</pub-id>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.694158</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brock</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Functional obstruction of the left ventricle: acquired aortic subvalvular stenosis</article-title>
          <source>Guys Hosp Rep</source>
          <year>1957</year>
          <volume>106</volume>
          <fpage>221</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="pmid">13480570</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brock</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Functional obstruction of the left ventricle (acquired aortic subvalvular stenosis)</article-title>
          <source>Guys Hosp Rep</source>
          <year>1959</year>
          <volume>108</volume>
          <fpage>126</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">13804574</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teare</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Asymmetrical hypertrophy of the heart in young adults</article-title>
          <source>Br Heart J</source>
          <year>1958</year>
          <volume>20</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">13499764</pub-id>
          <pub-id pub-id-type="doi">10.1136/hrt.20.1.1</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bos</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ommen</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Ackerman</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?</article-title>
          <source>Curr Opin Cardiol</source>
          <year>2007</year>
          <volume>22</volume>
          <fpage>193</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="pmid">17413275</pub-id>
          <pub-id pub-id-type="doi">10.1097/HCO.0b013e3280e1cc7f</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sigwart</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>112</volume>
          <fpage>293</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">16009810</pub-id>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000146788.30724.0A</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shehata</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Turkbey</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Vogel-Claussen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bluemke</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies</article-title>
          <source>Top Magn Reson Imaging</source>
          <year>2008</year>
          <volume>19</volume>
          <fpage>43</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="pmid">18690160</pub-id>
          <pub-id pub-id-type="doi">10.1097/RMR.0b013e31816fcb22</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramaraj</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Hypertrophic cardiomyopathy. Etiology, diagnosis and treatment</article-title>
          <source>Cardiology in Review</source>
          <year>2008</year>
          <volume>16</volume>
          <fpage>172</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">18562807</pub-id>
          <pub-id pub-id-type="doi">10.1097/CRD.0b013e318178e525</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishimura</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ommen</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Hypertrophic cardiomyopathy. The search for obstruction</article-title>
          <source>Circulation</source>
          <year>2006</year>
          <volume>114</volume>
          <fpage>2200</fpage>
          <lpage>2202</lpage>
          <pub-id pub-id-type="pmid">17116778</pub-id>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.660928</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ackerman</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?</article-title>
          <source>Curr Opin Cardiol</source>
          <year>2005</year>
          <volume>20</volume>
          <fpage>175</fpage>
          <lpage>181</lpage>
          <pub-id pub-id-type="pmid">15861004</pub-id>
          <pub-id pub-id-type="doi">10.1097/01.hco.0000163668.44141.89</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kervancioglu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ozbag</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kervancioglu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hatipoglu</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Kiliuc</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yilmaz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Deniz</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Echocardiographic and morphologic examination of left ventricular false tendons in human and animal hearts</article-title>
          <source>Clinical Anatomy</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>389</fpage>
          <lpage>395</lpage>
          <pub-id pub-id-type="pmid">12903060</pub-id>
          <pub-id pub-id-type="doi">10.1002/ca.10152</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ker</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Sub-aortic tendon induced ST-segment elevation &#x2013; a new echo-electrocardiographic phenomenon?</article-title>
          <source>Cardiovascular Ultrasound</source>
          <year>2009</year>
          <volume>7</volume>
          <fpage>13</fpage>
          <pub-id pub-id-type="pmid">19317911</pub-id>
          <pub-id pub-id-type="doi">10.1186/1476-7120-7-13</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shapiro</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Howat</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Crean</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Westgate</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>An echocardiographic study of localized subaortic hypertrophy</article-title>
          <source>European Heart Journal</source>
          <year>1986</year>
          <volume>7</volume>
          <fpage>127</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">2938953</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jategaonkar</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Butz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Burchert</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Horstkotte</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Faber</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Echocardiac features simulating hypertrophic obstructive cardiomyopathy in a patient with pheochromocytoma</article-title>
          <source>Clin Res Cardiol</source>
          <year>2009</year>
          <volume>98</volume>
          <fpage>195</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="pmid">19205779</pub-id>
          <pub-id pub-id-type="doi">10.1007/s00392-009-0748-z</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Symons</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fortune</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Greenbaum</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Dandona</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Cardiac hypertrophy, hypertrophic cardiomyopathy and hyperparathyroidism &#x2013; an association</article-title>
          <source>Br Heart J</source>
          <year>1985</year>
          <volume>54</volume>
          <fpage>539</fpage>
          <lpage>542</lpage>
          <pub-id pub-id-type="pmid">2932135</pub-id>
          <pub-id pub-id-type="doi">10.1136/hrt.54.5.539</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>XS</given-names>
            </name>
            <name>
              <surname>Donnell</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Felner</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Merlino</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography</article-title>
          <source>Am J Cardiol</source>
          <year>2009</year>
          <volume>103</volume>
          <fpage>411</fpage>
          <lpage>415</lpage>
          <pub-id pub-id-type="pmid">19166699</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.amjcard.2008.09.102</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koskenvuo</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Engblom</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kantola</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Hartiala</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Saraste</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kiviniemi</surname>
              <given-names>TO</given-names>
            </name>
            <name>
              <surname>Mononen</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Saraste</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance</article-title>
          <source>Clin Physiol Funct Imaging</source>
          <year>2009</year>
          <volume>29</volume>
          <fpage>177</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">19320660</pub-id>
          <pub-id pub-id-type="doi">10.1111/j.1475-097X.2008.00851.x</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
